TAT and cancer: In a previous study, BR2 showed about 4-fold higher efficiency of penetration into cancer cells than into normal cells compared with Tat, a well-known CPP (Koren and Torchilin, 2012), that has shown similar penetration efficiency regardless of cancer cell type (Torchilin and Levchenko, 2003; Lim et al., 2013).